S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB.
Feng PH, Yu CT, Chen KY, Luo CS, Wu SM, Liu CY, Kuo LW, Chan YF, Chen TT, Chang CC, Lee CN, Chuang HC, Lin CF, Han CL, Lee WH, Lee KY.
Feng PH, et al. Among authors: yu ct.
Oncotarget. 2018 Jan 10;9(7):7631-7643. doi: 10.18632/oncotarget.24146. eCollection 2018 Jan 26.
Oncotarget. 2018.
PMID: 29484139
Free PMC article.